Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Results
BLA submission for miv-cel in SPS completed with request for priority review
BLA submission for miv-cel in SPS completed with request for priority review